Promoting health and wellness is a critical part of ONE Shabbat as ONE people with ONE heart. The Myriad partnership is aligned with October Breast Cancer Awareness Month and will help promote education and awareness around the importance of understanding personal/family medical history and sharing this critical information with one’s healthcare provider,” said Rabbi Nitzan Bergman.

Myriad Genetics has partnered with the Jewish Community for over 20 years to accurately answer questions about hereditary disease and preventive treatment options. Approximately 1 in 40 individuals of Ashkenazi Jewish descent carry an altered BRCA1 or BRCA2 gene associated with increased risk of breast and ovarian cancer as well as prostate and pancreatic cancer. Myriad’s myRisk™ Hereditary Cancer test can help individuals and their healthcare providers determine if they are at increased risk for developing certain types of hereditary cancers and understand available  medical options.  For appropriate patients, coverage of the test is excellent. Under the Affordable Care Act, most insurance companies cover BRCA1 and BRCA2 genetic testing at 100% with no co-payment.

Recently, Myriad launched a digital resource called the Hereditary Cancer Quiz that guides individuals through a simple quiz to evaluate their personal/family cancer history and whether they may be candidates for genetic testing. At the end of the process, the tool generates a family history overview that can be shared with healthcare providers. A custom version of this quiz has been created for the BSP to help create awareness and education within the Ashkenazi community. 

About Myriad Genetics

Myriad Genetics is a leading personalized medicine company dedicated to making a difference in patients' lives through the discovery and commercialization of molecular diagnostic tests to assess a person's risk of developing disease, diagnose disease more accurately, assess risk of disease progression and recurrence, and guide treatment decisions. Myriad is focused on strategic initiatives to grow existing markets, diversify through the introduction of new products, including companion diagnostics, and expand internationally. For more information on how Myriad is making a difference, please visit the Company's website: www.myriad.com.  To take the Hereditary Cancer Quiz, please visit www.HereditaryCancerQuiz.com.

About The Baltimore Shabbat Project

The Baltimore Shabbat Project (BSP) is a unique, grassroots Jewish identity movement that is partnering with the international Shabbos Project. First launched in South Africa in 2013, this global initiative is spanning more than 500 cities this year, bringing together over 1,000,000 Jews from all backgrounds and traditions to celebrate ONE Shabbat as ONE people with ONE heart.”